Article Details
Retrieved on: 2025-01-08 21:05:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details FDA's warning to a CBD tampon manufacturer for marketing unapproved medical cannabis products, leading to product withdrawal from the U.S. market. This highlights the regulatory challenges surrounding cannabis-related medicinal products.
Article found on: www.marijuanamoment.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here